Revance Therapeutics Inc. sell Lokrim
Start price
11.05.24
/
20%
€3.12
Target price
11.05.25
-
Performance (%)
12.82%
End price
12.05.25
-
Summary
This prediction is currently being closed. The prediction currently has a disappointing performance of 12.82%. Lokrim has 20% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Revance Therapeutics Inc. | - | - | - |
| iShares Core DAX® | 0.734% | -0.964% | 17.910% |
| iShares Nasdaq 100 | -2.686% | -2.409% | 4.267% |
| iShares Nikkei 225® | -2.261% | -4.038% | 10.420% |
| iShares S&P 500 | -1.346% | -1.510% | 1.615% |
According to Lokrim what are the pros and cons of Revance Therapeutics Inc. for the foreseeable future?
Pros
Cons
Growths slower than the competition
Below average Marketposition
Little Investments for future growth
Few uniques
Probably not worthwhile Investment
Revenue decline/stagnation expected
Comments by Lokrim for this prediction
In the thread Revance Therapeutics Inc. diskutieren
Sell Revance Therapeutics Inc.
In the thread Trading Revance Therapeutics Inc.
Die von Lokrim gewählte maximale Laufzeit wurde überschritten